Dr Stephanie Barnes, a postdoctoral researcher in Dr Emily Osterweil’s lab at the Patrick Wild Centre, has been awarded a 2 year fellowship from FRAXA research organisation to test a potential new treatment strategy for fragile X syndrome. Stephanie will focus on a type of nerve signalling in the brain called NMDA receptor signalling which is known to be altered in fragile X syndrome.  She will test a novel treatment strategy to correct this signalling in a laboratory model of fragile X.  If successful this project may lead to the development of new treatments suitable for people with the condition.

More details of this and other FRAXA awards can be found here.